A 12-year-old from Bicester who was diagnosed with cancer at the age of seven is set to participate in this year's OX5 Run ...

Dark zone lymphoma includes aggressive B-cell lymphomas with shared molecular features. While some respond to escalated ...

XYF-19 is under clinical development by Xi'An Yufan Biotechnology and currently in Phase I for Burkitt Lymphoma.

In a collaborative effort involving more than 16 institutions around the globe, researchers from Simon Fraser University's (SFU) Department of Molecular Biology and Biochemistry have refined the ...

Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Burkitt Lymphoma - Global Clinical Trials Review, 2024" has been added to ResearchAndMarkets.com's offering. The clinical trial report provides an ...

Students and staff at a Sault Ste. Marie high school rallied around a 13-year-old who is battling Burkitt's lymphoma. They ...

EB-103 is under clinical development by Estrella Immunopharma and currently in Phase II for Follicular Lymphoma.

Shannon Charrette, a teacher at Korah Collegiate and Vocational School in Sault Ste. Marie, Ont., shaved her head during a ...

The recent hockey camp fundraiser Chase for a Cure that took place at the Ladner Leisure Centre in late December has been a resounding success raising more than $14,000 and counting. Chase Boutilier ...

The Medicine Game Brings Us All Together The Desert Dogs hiked up to Albany this weekend for the inaugural Tucker Out ...